In addition, GLP1/E and GLP1/GIP/Glucagon significantly improved insulin sensitivity, as denoted by ITT and HOMA-IR index, and decreased insulin levels
I asked him straightaway about fat
Continuing medical education efforts should emphasize evidence-based approaches to vitamin D therapy
You might and you might not
Our leadership team proposed gatekeeping with [an online weight-loss management program.] And theyre like, no, we cant afford this at all, so were cutting off [coverage for GLP-1 agonists for weight loss]
Semaglutide vs tirzepatide, and the honest 2026 picture on compounding Tirzepatide activates two gut-hormone receptors instead of one and showed larger average weight loss in trial data, but semaglutide has a longer track record and broader insurance familiarity and is the right choice for many patients